BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25653099)

  • 1. Assessment and management of hypertension in transplant patients.
    Weir MR; Burgess ED; Cooper JE; Fenves AZ; Goldsmith D; McKay D; Mehrotra A; Mitsnefes MM; Sica DA; Taler SJ
    J Am Soc Nephrol; 2015 Jun; 26(6):1248-60. PubMed ID: 25653099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension, living kidney donors, and transplantation: where are we today?
    Rossi AP; Vella JP
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):154-64. PubMed ID: 25704353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of hypertension in post transplant.
    Kaul A; Sharma RK; Gupta A; Singh U
    J Assoc Physicians India; 2010 Apr; 58():221-4. PubMed ID: 21046874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension after kidney transplant.
    Mangray M; Vella JP
    Am J Kidney Dis; 2011 Feb; 57(2):331-41. PubMed ID: 21251543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of hypertension after kidney transplantation.
    Chatzikyrkou C; Menne J; Gwinner W; Schmidt BM; Lehner F; Blume C; Schwarz A; Haller H; Schiffer M
    J Hypertens; 2011 Dec; 29(12):2283-94. PubMed ID: 21970935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-transplant nephropathy and arterial hypertension].
    Oko A; Idasiak-Piechocka I; Czekalski S
    Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive medication and renal allograft failure: a North American Pediatric Renal Transplant Cooperative Study report.
    Sorof JM; Sullivan EK; Tejani A; Portman RJ
    J Am Soc Nephrol; 1999 Jun; 10(6):1324-30. PubMed ID: 10361872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cyclosporine induced hypertension: Results from a long-term observational study using different antihypertensive medications.
    Marienhagen K; Lehner F; Klempnauer J; Hecker H; Borlak J
    Vascul Pharmacol; 2019 Apr; 115():69-83. PubMed ID: 29933079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial hypertension following renal transplantation in children-a short-term study.
    Nagasako SS; Koch Nogueira PC; Machado PG; Medina Pestana JO
    Pediatr Nephrol; 2003 Dec; 18(12):1270-4. PubMed ID: 14586678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in kidney transplantation.
    Castillo-Lugo JA; Vergne-Marini P
    Semin Nephrol; 2005 Jul; 25(4):252-60. PubMed ID: 16202698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for and management of post-transplantation cardiovascular disease.
    Fellström B
    BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of antihypertensive drugs at 1 year after kidney transplantation.
    Kislikova M; Seras M; Monfa E; Rodrigo E; Fernandez-Fresnedo G; Ruiz JC; Arias M
    Transplant Proc; 2015; 47(1):76-7. PubMed ID: 25645775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.
    Formica RN; Friedman AL; Lorber MI; Smith JD; Eisen T; Bia MJ
    Nephrol Dial Transplant; 2006 May; 21(5):1389-94. PubMed ID: 16431893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension, antihypertensive agents and outcomes following renal transplantation.
    Tutone VK; Mark PB; Stewart GA; Tan CC; Rodger RS; Geddes CC; Jardine AG
    Clin Transplant; 2005 Apr; 19(2):181-92. PubMed ID: 15740553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of resistant hypertension in renal transplant patients.
    Arias M; Fernández-Fresnedo G; Gago M; Rodrigo E; Gómez-Alamillo C; Toyos C; Allende N
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv36-8. PubMed ID: 23258809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension after renal transplantation.
    Schwenger V; Zeier M; Ritz E
    Ann Transplant; 2001; 6(4):25-30. PubMed ID: 12035455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.